management of congenital heart disease in infants

56
MANAGEMENT OF CONGENITAL HEART DISEASE IN INFANTS Dr Syed Raza Consultant Cardiologist

Upload: smsraza

Post on 11-May-2015

5.761 views

Category:

Health & Medicine


6 download

DESCRIPTION

PRESENTATION FOR NON CARDIOLOGISTS

TRANSCRIPT

Page 1: Management of congenital heart disease in infants

MANAGEMENT OF CONGENITAL HEART DISEASE IN INFANTS

Dr Syed RazaConsultant Cardiologist

Page 2: Management of congenital heart disease in infants

Objectives

• Prevalence• Common congenital heart defects• Diagnostic Workup• Management

Page 3: Management of congenital heart disease in infants

Size Of The Problem !

• Commonest birth defect• 33% of all birth defects• In US alone 35,000 babies are born with heart

defects every year.• Prevalence of 8 per 1000 births. • 1 million grown up adults with heart defects

Page 4: Management of congenital heart disease in infants

Size of The Problem!

• Incidence is higher in pre-term infants. • Can be as high as 10-15% in infants who

have a parent with CHD• 5-10% association with abnormal

karyotyping.• Females - more prone to have PDA and ASD• Males - more prone to have valvular aortic

stenosis, coarctation of the aorta, TOF and Transposition of the Great Vessels

• Maternal rubella is associated with PDA

Page 5: Management of congenital heart disease in infants
Page 6: Management of congenital heart disease in infants

Other Associated Birth Defects (TRAVEL)

• T – Tracheoesophageal fistula • R – Renal anomalies • A – Anal atresia • V – Vertebral anomalies• E – Esophageal atresia• L – Limb defects

Page 7: Management of congenital heart disease in infants
Page 8: Management of congenital heart disease in infants

How to deal with the problem?

• Family physicians must know how to screen for cardiac defects in infants.

• Must be competent to stabilize the infant and work as a team with Paediatric Cardiologist and Cardiac surgeon.

• Be able to provide psychosocial support to the family.

Page 9: Management of congenital heart disease in infants

CLASSIFICATION

• – Acyanotic - Left-to-right shunt - oxygenated to un

oxygenated blood

– Cyanotic - Right-to-left shunt - deoxygenated blood to oxygenated blood

– Hemodynamic and Blood Flow Patterns • Increased pulmonary flow• Decreased pulmonary flow• Obstruction to blood flow (out of the heart)

Page 10: Management of congenital heart disease in infants

Common Types of CHD

ACYANOTICVentricular septal defect (Commonest –

Membranous type)Atrial septal defect Atrioventricular canal defect Pulmonary stenosis,Patent ductus arteriosus Aortic stenosis andCoarctation of the aorta

Page 11: Management of congenital heart disease in infants

Types of CHD – contd:

CYANOTIC

Tetralogy of Fallot Transposition of the great arteries.

Page 12: Management of congenital heart disease in infants

Heart Anatomy

Page 13: Management of congenital heart disease in infants

Patent Ductus Arteriosus

Page 14: Management of congenital heart disease in infants

Atrial Septal Defect

Page 15: Management of congenital heart disease in infants

Ventricular Septal Defect

Page 16: Management of congenital heart disease in infants

Hypoplastic Left Heart Syndrome

Page 17: Management of congenital heart disease in infants

Coarctation of the Aorta

Page 18: Management of congenital heart disease in infants

Tetralogy of Fallot

Page 19: Management of congenital heart disease in infants

Tetrology of Fallot

Page 20: Management of congenital heart disease in infants

Transposition of the Great Arteries

Page 21: Management of congenital heart disease in infants

Problems Associated :

• Acyanotic CHD Congestive Cardiac Failure

• Cyanotic CHD Hypoxia

Page 22: Management of congenital heart disease in infants

History Taking

• Must be careful. Some of the symptoms are very subtle.

• Obtain a detailed prenatal history including exposure to infections (cytomegalovirus, toxoplamosis, rubella or varicella), medication usage, drug and alcohol use, nutrition and exposure to radiation.

Page 23: Management of congenital heart disease in infants

Associated Risk Factors

• Diabetes • Family history of CHD • Alcohol• Exposure to drugs such as Phenytoin,

Warfarin, Lithium, Thalidomide etc.• First-trimester rubella exposure (PDA)• Residence at high altitudes (PDA)• Karyotype abnormalities

Page 24: Management of congenital heart disease in infants

How to suspect CHD?

• Feeding problems• Fatigue and excessive sweating• Severe growth impairment• Recurrent chest infection

Page 25: Management of congenital heart disease in infants

CLINICAL SIGNS

• Signs of poor growth• Tachypnea• Sub costal recession• Tachycardia• Cyanosis• Peri orbital oedema• Murmur

Page 26: Management of congenital heart disease in infants
Page 27: Management of congenital heart disease in infants

MURMUR

• The presence or absence of a heart murmur is unreliable

• Murmur at birth that disappears before baby’s discharge from hospital – likely PDA

• Murmur is not present in many severe forms of CHD, such as tricuspid atresia, Coarctation of the aorta and Transposition of the great vessels.

• The intensity of the murmur is unrelated to the severity of the abnormality.

Page 28: Management of congenital heart disease in infants

Pulmonary vs Cardiac Cyanosis

Suspicion of cyanosis should be confirmed by pulse oximetry.

Pulmonary disorders - administration of 100 percent oxygen usually increases the arterial oxygen saturation to at least 95 percent. Cyanotic CHD - oxygen saturation will only increase to 80 to 85 percent.

Page 29: Management of congenital heart disease in infants

Heart Failure Signs

Presence of third heart sound

Lung crepitations

Oedema – late sign (Peri-orbital before leg)

Hepatomegaly

Ascitis

Page 30: Management of congenital heart disease in infants

INVESTIGATIONS

• ECG- a normal ECG does not exclude the presence of CHD if index of suspicion is high.

• Chest radiographs - cardiomegaly and increased pulmonary vascular markings.

A serious underlying heart defect is unlikely if ECG and CXR are normal.

Page 31: Management of congenital heart disease in infants

Investigations : contd

• Echocardiogram - primary diagnostic test.• Phonocardiogram - heart sounds are recorded and

displayed as a diagram• MRI - used to evaluate heart structure, size or blood

flow

• Lab tests - Hb and Hct (polycythemia), • ESR (rheumatic fever, Kawasaki disease,

myocarditis), • ABG (presence of a right to left shunt), • Clotting times (PT, PTT) and platelet count, • Na, K, digoxin level

Page 32: Management of congenital heart disease in infants

DIAGNOSIS

• Studies suggest that 30 to 60 percent of congenital heart defects can be detected prenatally by high resolution four-chamber transvaginal echocardiogram.

• Foetal echocardiography with outflow-tract views can be particularly helpful in detecting anomalies of the great arteries.

• SCAN USUALLY PERFORMED AT 18-22 WEEKS

Page 33: Management of congenital heart disease in infants

Cardiac Catheterization

• Can be either diagnostic or interventional– Pressures in the heart can be measured– CO can be evaluated– Blood samples can be obtained and tested (O2

sat)– Contrast can be injected to study blood flow,

vessels and chambers– Balloon angioplasty can be performed to

stretch stenosed areas or blockages in vessels– Can study electrical activity of the heart

Page 34: Management of congenital heart disease in infants

MRI

• Provides structural details when echocardiogram images are not optimum.

• Magnetic resonance imaging provides excellent anatomic evaluation particularly if repair is contemplated.

• Yields even more information than angiography/catheterization.

Page 35: Management of congenital heart disease in infants

TREATMENT AIMS

• 1) improving cardiac function

• 2) removing accumulated fluid and sodium

• 3)decrease cardiac demands

• 4) improve tissue O2

• 5) Improve nutrition and hydration

• 6)Prevention of infection

• 7) Patient and family support

Page 36: Management of congenital heart disease in infants

TREATMENT OPTIONS

• MEDICATION• CLOSURE DEVICE THERAPY• SURGERY• IMPROVING GENERAL WELL BEING

Page 37: Management of congenital heart disease in infants

Heart Failure Management

• Diuretics - Lasix, spironalactone, thiazides (may need K replacement)

• Improve contractility – Digoxin. • Decrease afterload - hydralazine

(vasodilator), nifedipine (Ca channel blocker), nipride (vasodilator), or captopril (ACE inhibitor)

Page 38: Management of congenital heart disease in infants

Heart Failure Management: Cont’d

Improve oxygenation - administer O2 as needed by hood, mask or nasal prongs.

Adequate nutrition is also important may need six to eight small meals daily rather than 3 large meals, may need tube feedings

Page 39: Management of congenital heart disease in infants

Important Points about Care of the Child with a Heart Defect

• Parents taking a child with a heart defect home should have discharge planning which includes name/number of the specialist and all emergency numbers.

• Instruction in what to do if child becomes cyanotic, CPR training.

• Should not allow a child with a cyanotic heart defect or severe aortic stenosis to cry for extended periods of time.

Page 40: Management of congenital heart disease in infants

CLOSURE DEVICE : AMPLATZ

Page 41: Management of congenital heart disease in infants

CLOSURE DEVICE

Page 42: Management of congenital heart disease in infants

BALOON VALVULOPLASTY

Page 43: Management of congenital heart disease in infants

BALOON VALVULOPLASTY

Page 44: Management of congenital heart disease in infants

SURGERY

Page 45: Management of congenital heart disease in infants

Nutrition Requirements

• Adequate nutrition is extremely important in infants with CHD

• Infants who are unable to gain sufficient weight with breast feeding, supplementation may be provided:

Options include a formula with a high caloric density, nocturnal enteral feeding or continuous 24-hour feeding with a nasogastric or duodenal tube

Page 46: Management of congenital heart disease in infants

Nutrition Requirements: Contd.

• Don’t usually have to restrict sodium intake (regulates water balance)

• Need vitamin supplements and maybe an iron supplement

Page 47: Management of congenital heart disease in infants

Prophylaxis Against Bacterial Endocarditis: ACC/AHA Guidelines

• Patients who have complex cyanotic congenital heart disease (e.g., single-ventricle states, transposition of the great arteries, tetralogy of Fallot). (Level of Evidence: C)• Patients with surgically constructed systemic pulmonary shunts or conduits. (Level of Evidence: C)• Patients with congenital cardiac valve malformations, particularly those with bicuspid aortic valves.

Page 48: Management of congenital heart disease in infants

Infective Endocarditis Prophylaxis

• Completely repaired congenital heart defect with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure. (Level of Evidence: B)

Page 49: Management of congenital heart disease in infants

Prophylaxis Not Recommended

• Patients with isolated secundum atrial septal

defect. (Level of Evidence: C)• Patients 6 or more months after successful surgical or percutaneous repair of atrial septal defect, ventricular septal defect, or patent ductus arteriosus. (Level of Evidence: C)

Page 50: Management of congenital heart disease in infants

VACCINATION

Pneumococcal vaccine is recommended at two years of age

Influenza vaccine should be given yearly beginning at age six months.

MMR at 12 months instead of 15

Page 51: Management of congenital heart disease in infants
Page 52: Management of congenital heart disease in infants

Psychological Issues

• The diagnosis of CHD is cause for much distress amongst family members

• Parents experience shock, denial, guilt, anger, despair or confusion on learning that their infant has a cardiac defect.

• Greater stress if requires surgical intervention.

Page 53: Management of congenital heart disease in infants

Effect of High Demand of Child’s Medical Treatment and Care

• Parents and care givers forced to give up jobs and careers

• Easy fatigability• Distress and irritability• No leisure time• Loss of resources• Depression

Page 54: Management of congenital heart disease in infants

Handling Psychological Stress

• Reinforcement of the positive, normal attributes of the child helps the family see the child as an individual with many of the same needs as healthy children

• Consultation with a mental health professional may help to cope with the challenge.

Page 55: Management of congenital heart disease in infants

General Physician’s Role

Important link between family and specialist Physician should provide correct information

and clear any doubts and misconceptions.Provide reassurance and maintain positive

attitude.Educate the family .Provide moral supportArrange for support group and psychological

help.

Page 56: Management of congenital heart disease in infants

THANK YOU

ANY QUESTIONS ?